The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $48.58

Today's change-0.25 -0.51%
Updated November 20 2:42 PM EST. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $48.58

Today's change-0.25 -0.51%
Updated November 20 2:42 PM EST. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA crosses below 50-day moving average

Fresenius Medical Care AG & Co KGaA is lower today, dropping (U.S.)$0.25 or 0.51% to (U.S.)$48.58 and crossing below its 50-day moving average. Over the last five days, shares are unchanged, but are currently 3.26% below its 52-week high. This security has outperformed the S&P 500 by 7.40% during the last year.

Key company metrics

  • Open(U.S.) $48.60
  • Previous close(U.S.) $48.83
  • High(U.S.) $48.70
  • Low(U.S.) $48.54
  • Bid / Ask(U.S.) $48.58 / (U.S.) $48.59
  • YTD % change+15.10%
  • Volume55,311
  • Average volume (10-day)221,862
  • Average volume (1-month)308,697
  • Average volume (3-month)230,357
  • 52-week range(U.S.) $38.05 to (U.S.) $50.22
  • Beta0.45
  • Trailing P/E20.27×
  • P/E 1 year forward20.81×
  • Forward PEG2.36×
  • Indicated annual dividend(U.S.) $0.53
  • Dividend yield1.09%
  • Trailing EPS(U.S.) $2.40
Updated November 20 2:42 PM EST. Delayed by at least 15 minutes.
S&P TSX0.17%Sector:Industry:

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue4,3364,4714,5484,021
Total other revenue--------
Total revenue4,3364,4714,5484,021
Gross profit1,4251,4951,5921,366
Total cost of revenue2,9112,9762,9562,655
Total operating expense3,7273,8883,8973,346
Selling / general / administrative801900923637
Research & development28353236
Depreciation / amortization--00--
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income609583651675
Interest income (expense), net non-operating-98-89-121-91
Gain (loss) on sale of assets--------
Other--------
Income before tax523488559591
Income after tax371338377409
Income tax, total152151182182
Net income309269308333
Total adjustments to net income--------
Net income before extra. items309269308333
Minority interest-62-69-69-76
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items309269308333
Inc. avail. to common incl. extra. items309269308333
Diluted net income309269308333
Dilution adjustment------0
Diluted weighted average shares307307306307
Diluted EPS excluding extraordinary itemsvalue per share1.010.881.011.09
Dividends per sharevalue per share--0.000.00--
Diluted normalized EPSvalue per share1.010.881.011.09